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Biodegradable polymers open the way to treatment of heart
disease using transient implants (bioresorbable vascular scaffolds,
BVSs) that overcome the most serious complication associated
with permanent metal stents—late stent thrombosis. Here, we
address the long-standing paradox that the clinically approved
BVS maintains its radial strength even after 9 mo of hydrolysis,
which induces a ∼40% decrease in the poly L-lactide molecular
weight (Mn). X-ray microdiffraction evidence of nonuniform hy-
drolysis in the scaffold reveals that regions subjected to tensile
stress during crimping develop a microstructure that provides
strength and resists hydrolysis. These beneficial morphological
changes occur where they are needed most—where stress is local-
ized when a radial load is placed on the scaffold. We hypothesize
that the observed decrease in Mn reflects the majority of the
material, which is undeformed during crimping. Thus, the global
measures of degradation may be decoupled from the localized,
degradation-resistant regions that confer the ability to support
the artery for the first several months after implantation.
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Coronary heart disease (CHD) restricts the flow of blood tothe heart muscles due to the accumulation of plaque on the
walls of the arteries surrounding the heart. Cardiovascular disease
(CVD) accounted for 31% of all deaths worldwide in 2010 (1) and
claimed more lives than all cancers combined in the United States
in 2015 (2)—with over 40% of all CVD deaths due to CHD (1).
The current standard of care for CHD is to implant a drug-eluting
metal stent (DES) to hold the vessel open [>1 million implanted
in 2008 in the United States alone (3)]. However, the rigid nature
of metal stents permanently restricts arterial vasomotion and in-
duces potentially fatal complications such as late stent thrombosis
(LST) (4, 5). Bioresorbable vascular scaffolds (BVSs, Fig. 1A) are
emerging as an alternative that, unlike metal stents, temporarily
support the occluded artery for 6–9 mo and are completely
resorbed in 2–3 y (6–8). Five-year follow-up in the first-in-man
trials for BVS (101 patients, 2009) reported restoration of arte-
rial vasomotion and dilation with no incidence of LST in properly
deployed and well-apposed scaffolds (9–11). However, the second
randomized clinical trial for BVS (335 patients, 2011–2013) in-
dicated an increase in thrombosis (within 1 y) for BVS compared
with DES (12), motivating further improvements. The greater
thickness of BVS (∼150 μm) relative to metal stents (∼80 μm) may
contribute to the reported increase in thrombosis (13). The key to
thinner scaffolds is increased strength that lasts at least 3 mo after
implantation, motivating the present study of the relationships
between scaffold microstructure, mechanical strength, and hy-
drolytic degradation during the first 18 mo after deployment.
The structural material of the first clinically approved BVS
[CE Mark in 2011 (4), FDA approval in 2016 (14)] is the semi-
crystalline polymer poly L-lactide (PLLA), which hydrolyzes into
L-lactic acid and is metabolized by the body (15–18). Pure PLLA
is a surprising choice for a BVS as it is widely described as a
brittle material (literature values of fracture strain <10% at
physiological conditions) (19, 20). PLLA blends (21, 22) and
copolymers (23–25) that offer superior ductility failed to progress to
the clinic as they prematurely lose strength due to relatively rapid
hydrolysis (26, 27). The usual brittle character of PLLA was over-
come via careful selection of processing conditions to impart ductile
character to a BVS that remains strong for the first 9 mo after
implantation. Manufacture of a BVS begins with a nearly amor-
phous PLLA preform (a tube with an inner diameter, ID, of
0.64 mm and outer diameter, OD, of 1.69 mm) (28) that is trans-
formed into a vascular scaffold by a sequence of “tube expansion”
(biaxial elongation into a uniform, thin-walled, oriented, glassy tube
with an OD of 3.5 mm and thickness of ∼150 μm), “laser-cutting” a
strut lattice from the tube, and “crimping” onto a balloon catheter
(28, 29). Recent microdiffraction measurements reveal that this
processing history creates important structural transformations
during crimping (we return to this in Discussion) that facilitate
deployment without fracture (28). However, surviving deployment
is only the first step for a BVS toward clinical success; it is imper-
ative for the deployed scaffold to maintain radial strength in the
artery for an additional 3–6 mo despite hydrolytic degradation.
In agreement with the literature on PLLA (30), molecular
weight (Mn) reduction of BVSs in vitro matches that in vivo (SI
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Appendix, Fig. S1A), suggesting that the strength and structure
observed during hydrolysis in vitro are relevant to hydrolysis in vivo
as well. For the material and processing conditions examined here,
deployed BVSs maintain their radial strength for more than 9 mo
(SI Appendix, Fig. S1 D and E) (31); this is surprising in view of the
substantial decrease ofMn over this time period (SI Appendix, Fig.
S1 A and B), which is associated with scission of “tie chains” that
connect lamellar crystals and provide load-bearing capability to the
polymer (19, 32). The apparent disconnect between the strength
andMn of PLLA during hydrolysis is well documented (26, 33–35),
but to the best of our knowledge there is no study that reconciles
this discrepancy. The intriguing combination of Mn decrease
without loss of strength is even more puzzling in light of a recent
study that found extensive degradation and loss of strength in less
than 4 mo of hydrolysis in scaffolds made from a different grade of
PLLA and under different processing conditions (36). Here, we use
X-ray microdiffraction to shed light on microstructural features
that play a critical role in mitigating the effects of hydrolysis and
provide lasting strength to the clinically approved BVS.
Results
We focus on the effects of hydrolysis at U-crests (defined in Fig.
1 A and B) as these regions are the most susceptible to fracture
under loading. We compare the structure of scaffolds that have
been crimped, deployed, and hydrolyzed for 9 mo (9 M) and 18 mo
(18 M) to the as-deployed scaffold (0 M) to understand the pro-
gression of hydrolysis in the BVS. We describe hydrolysis effects
starting with the more extreme 18 M case, which captures the
PLLA microstructure as the scaffold begins to disintegrate, and
then the more nuanced 9 M case, where the microstructure is still
strong enough to support the artery. We begin by examining po-
larized light micrographs of ∼15-μm-thick sections of U-crests cut
from the ID to the OD of the scaffolds (ID/OD indicated in Fig.
1C). Specifically, the micrographs reveal three types of regions
based on the deformation imposed on them during crimping: The
vast majority of the material is undeformed (e.g., arms, defined in
Fig. 1A), a small region near the inner bend (IB, defined in Fig.
1C) is compressed along the θ direction, and a small region near
the outer bend (OB, defined in Fig. 1C) is elongated in the θ
direction. Within this context, we move to synchrotron X-ray
microdiffraction results, which reveal gradients in the progression
of hydrolysis that are distinct for each of the three types of regions.
Polarized light micrographs of 18 M sections reveal a material
that is brittle, heterogeneous (e.g., 18 M, Fig. 1D; the bright blue-
green microdomains have retardation >600 nm), and riddled
with fissures preferentially oriented along the θ direction [18 M,
Fig. 1D; see SI Appendix, Fig. S2 for micrographs cut from other
(n = 3) 18 M scaffolds]. In contrast, the 9 M sections maintain
structural integrity and, apart from a subtle increase in re-
tardation, appear similar to their 0 M counterparts (Fig. 1D). In
the vicinity of the diamond-shaped void of the U-crest (Fig. 1B),
the 9 M sections have regions that appear orange-red (high re-
tardation), indicating a material of stronger-than-average orien-
tation. Regions that appear pale gray to black on the IB on either
side of the diamond-shaped void indicate a material with low
orientation in the plane of the section that is present upon de-
ployment (0 M) and remains after 9 M hydrolysis. These strong
variations in structure are consistently observed in 0 M and 9 M
scaffolds (n = 3 for each; SI Appendix, Figs. S3 and S4) and are
confined to a region that extends ∼100 μm to each side of the
symmetry plane (defined in 0 M, Fig. 1D, Right). Therefore, we
take advantage of the fine spatial resolution of X-ray micro-
diffraction (200-nm spot size) to probe the microstructure in these
localized regions to find clues to the lasting strength of the BVS.
Consistent with the literature (26, 27, 37), 18 M of hydrolysis
produces a decrease in amorphous content and a concomitant in-
crease in crystallinity: The intensity of the amorphous halo at 18 M
is approximately half that of 0 M (compare 18 M with 0 M in Figs.
2 and 3 and SI Appendix, Fig. S5B, Left) and the intensity of the
(110)/(200) peaks increases dramatically (approximately threefold
increase at 18 M relative to 0 M, Figs. 2 and 3 and SI Appendix, Fig.
S5C, Left). Microdiffraction data acquired on the bright blue-green
microdomains (18 M, Fig. 1D) indicate that these regions possess a
greater number of oriented crystalline unit cells compared with the
surrounding material (SI Appendix, Fig. S7). In contrast, a scaffold
made with a different grade of PLLA, manufacturing process, and
strut geometry undergoes rapid degradation and shows loss of
Fig. 1. Microscopy provides a coarse-grain map of the impact of hydrolysis on
the microstructure of BVSs. (A) An optical micrograph of a deployed BVS de-
fining the terms “W-crest,” “Y-crest,” “link,” “arm,” “U-crest,” and “ring.”
Adapted from ref. 6, with permission from Elsevier. (B) Scanning electron
micrograph highlighting diamond-shaped voids in U-crests after deployment.
(C) Schematic diagram of a U-crest indicating the IB, where the voids occur, the
OB, and the OD surface; the ID surface is hidden. (D) Polarized light micro-
graphs (orientation of analyzer and polarizer shown as A and P) reveal
structural anisotropies in 15-μm-thick sections cut from scaffolds hydrolyzed
for 0 mo (0 M), 9 mo (9M) and 18 mo (18 M). The distance shown indicates the
position of each section relative to the ID (e.g., the 0 M–15 μm section is 15 μm
from the ID). The retardation of the as-deployed scaffold (0M) is highest in the
region between the diamond-shaped void and the OB and increases with ra-
dial position from the OD to ID (retardation ∼400 nm near the OD and
∼500 nm at the ID); this gradient in retardation is still present after 9 M hy-
drolysis (D, 9 M) and has its origins in scaffold manufacture (see origin of
r-gradient in retardation in SI Appendix). In contrast, the retardation does not
systematically vary from the OD to ID after 18 M of hydrolysis.
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crystallinity and orientation in the interior within 110 d of hydro-
lysis (36). Microdiffraction data on the clinically approved scaffold
at 18 M (540 d) indicate an increase in the degree of crystallinity
and retention of strong orientation along the θ direction (SI Ap-
pendix, Fig. S5 C and D, Left and SI Appendix, Figs. S8 and S9).
The differences that result from 9 mo of hydrolysis are less ob-
vious, particularly for diffraction patterns acquired near the OB
(compare 0 M and 9 M patterns, Fig. 2, Right). At 0 M, scattering
patterns acquired at the symmetry plane are nearly indistinguish-
able for all microdiffraction positions (see SI Appendix, Figs. S10
and S11 for X-ray data and SI Appendix, Fig. S12 for quantitative
characteristics of all five 0 M sections). However, at the 9 M
symmetry plane, there is a clear gradient in morphology from the
IB to the OB: The amorphous halo at the IB is ∼20% lower rel-
ative to the OB, which has intensity comparable to that of the as-
deployed scaffold (compare 0 M with 9 M, Figs. 2 and 3 for
microdiffraction data and SI Appendix, Fig. S5B, Left for quanti-
tative characteristics of the sections cut ∼60 μm from the ID). The
decrease in the amorphous halo indicates that hydrolysis has pro-
gressed at the IB. Retaining intensity in the amorphous halo sug-
gests that the material near the OB of U-crests resists hydrolysis
during the first 9 mo (see SI Appendix, Figs. S13–S22 for X-ray data
and SI Appendix, Figs. S23–S25 for quantitative characteristics of
all five 9 M sections).
The retention of the amorphous halo near the OB is also ob-
served along line scans that are offset from the 9 M symmetry
plane by ∼40 μm in the θ direction; the IB is susceptible to hy-
drolysis, while the amorphous halo at the OB is comparable to
that of the as-deployed 0 M scaffold (relative to 0 M, the amor-
phous halo at IB has decreased more than 20% in 9 M; see Figs.
4B and 5B and SI Appendix, Fig. S5B, Middle). In contrast,
microdiffraction line scans that are offset from the symmetry plane
by ∼180 μm in the θ direction do not vary with position from IB to
OB (Figs. 4A and 5A), consistent with the highly uniform mor-
phology in portions of the scaffold that were undeformed during
crimping and deployment. All of the patterns acquired ∼180 μm
from the symmetry plane of 9 M show a weak amorphous halo
similar to the IB near the symmetry plane (cf. Fig. 4 A–C, 15–
20 μm; also see SI Appendix, Fig. S5B, Right and SI Appendix, Fig.
S23, Right). The ability of the OB near the symmetry plane to
resist degradation correlates with its unique microstructure (28),
which only exists in regions subjected to elongational deformation
during crimping.
Fig. 2. Selected wide-angle X-ray microdiffraction patterns for the 15-μm-thick section cut at a radial position ∼60 μm from the ID for BVSs subjected to
hydrolysis for (A) 0 M, (B) 9 M, and (C) 18 M. (i) Polarized light micrographs show the position of microdiffraction acquisitions (white squares labeled with
their distance from the IB correspond to patterns in ii; white dashed lines indicate where images focused on specific X-ray marks were stitched together). (ii)
Two-dimensional diffraction patterns use an identical logarithmic color scale [colors vary from 0 (deep blue) to 3 (deep red) counts] and q-scale (indicated at
bottom right). Corresponding 1D patterns are given in Fig. 3 and quantitative characteristics of the amorphous and crystalline features of the 2D patterns are
presented in SI Appendix, Fig. S5. Due to the structural discontinuities that develop after 18 mo of hydrolysis, the path from the IB to the OB of the 18 M
section is nearly twice that of its 0 M or 9 M counterpart (∼120 μm from IB to OB in C, i compared with ∼60 μm in A and B, i).
Fig. 3. Selected 1D microdiffraction profiles averaged (Left) azimuthally,
I(q), and (Right) radially, I(φ) for WAXS patterns acquired on a section cut
∼60 μm from the ID of a (A) 0 M, (B) 9 M and (C ) 18 M scaffold. The position
at which each X-ray pattern was acquired is indicated in the legend (same
positions as the 2D patterns in Fig. 2). Radial averaging was performed in
the vicinity of the (110)/(200) reflection: q ∈ [1.08–1.24 Å−1].
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Discussion
There are four questions we consider in relation to our proposed
resolution of the seemingly contradictory effects of hydrolysis on
Mn and strength. Is the fraction of the scaffold that is resistant to
hydrolysis small enough that the decrease in overall Mn could
plausibly be dominated by the rest of the material? If the arms
and links undergo faster hydrolysis than the U-crests, why do
they remain intact at 9 mo? Is there evidence that loss of strength
occurs first in the arms and links? Is there evidence that U-crests
make particularly important contributions to scaffold radial
strength? We address each of these in turn.
To estimate the fraction of the total material that resists hy-
drolysis in the scaffold, we use numerous optical and SEM images
to calculate an upper bound for the volume of material near the
OB that has a well-preserved amorphous halo at 9 M. We include
material that is ∼100 μm on each side of the symmetry plane of a
deployed U-crest, which has an average IB-to-OB distance of
∼80 μm and an average ID-to-OD thickness of ∼140 μm. The
resulting upper bound for the volume of material that resists
degradation is ∼1.3 × 10−3 mm3 (mass ∼1.7 μg per U-crest), which
is <3% of the volume of scaffold per U-crest (SI Appendix, Fig.
S26). The decrease in Mn as a function of hydrolysis time is eval-
uated by dissolving an entire scaffold for gel-permeation chroma-
tography (GPC) measurements (SI Appendix, Fig. S1A); the GPC
traces indicate that the presence of ∼3% of chains that retain the
initial distribution of molecular weights would be hidden under the
GPC trace of the rest of the material (SI Appendix, Fig. S1B).
Therefore, it is plausible that the apparent rate of hydrolysis av-
eraged over the whole scaffold might not detect the local variations
indicated by the microdiffraction results.
Our hypothesis might be perceived as creating another co-
nundrum: If the arms and links are undergoing significant hy-
drolysis during the first 9 mo, how does the scaffold radial strength
remain unchanged? The answer to this lies in the geometry of the
cross-section of load-bearing elements and their orientation rela-
tive to the load. The links and arms have a substantially greater
cross-section than the U-crests. Specifically, at the symmetry
plane, the cross-section of the U-crest is ∼70 μm × 140 μm, which
is less than half that of the arms and links (135 μm × 150 μm). The
links and arms are also oriented such that they either experience
negligible stress during radial loading (links) or are subjected to a
modest torque (arms). The combination of a large cross-section
and little or no load being imposed results in negligible strain in
these portions of the scaffold during radial loading. Consequently,
Fig. 4. Selected wide-angle X-ray microdiffraction patterns of the 9 M sample (section ∼60 μm from the ID) acquired along lines that are (A) ∼180 μm, (B)
∼40 μm, and (C) ∼0 μm from the symmetry plane. (i) Polarized light micrographs show the position of microdiffraction acquisitions (white squares labeled
with their distance from the IB correspond to patterns in ii; white dashed lines indicate where images focused on specific X-ray marks were stitched together).
(ii) Two-dimensional diffraction patterns use an identical logarithmic color scale [colors vary from 0 (deep blue) to 3 (deep red)] and q-scale (indicated at
bottom right). Corresponding 1D patterns are given in Fig. 5 and quantitative characteristics of the amorphous and crystalline features of the 2D patterns are
presented in SI Appendix, Fig. S5.
Fig. 5. Selected 1D microdiffraction profiles averaged (Left) azimuthally,
I(q), and (Right) radially, I(φ), for WAXS patterns acquired on the 9 M sample
(section ∼60 μm from the ID) along lines located (A) ∼180 μm, (B) ∼40 μm,
and (C) ∼0 μm from the symmetry plane. Radial averaging was performed
in the vicinity of the (110)/(200) reflection: q ∈ [1.08–1.24 Å−1]. The legend
indicates the position along the line (corresponding to the 2D patterns in
Fig. 4).
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the arms and links are unlikely to fail even if their strength de-
creases significantly during the first 9 mo.
If our hypothesis regarding the previously unexplained discon-
nect between the effects of hydrolysis on Mn and strength is cor-
rect, the drop inMn in the arms and links might be accompanied by
a decrease in strength. We checked for evidence that the links and
arms lose strength earlier than the U-crests. Although the evidence
we found is indirect and qualitative, it does accord with the ex-
pectation that strength decreases earlier where hydrolysis proceeds
faster. First, in the sections cut from the scaffold after 18 mo
of hydrolysis, many of the microtomed sections showed fissures
extending in the θ direction entirely through a link (SI Appendix,
Fig. S2 A and B, Bottom). Similarly, we saw several sections that
had fissures extending in the θ direction entirely through an arm
(SI Appendix, Fig. S2). In contrast, the U-crests were intact. Sec-
ond, photographs of scaffolds after 20 mo and 22 mo of hydrolysis
show that they fall apart in a way that leaves rings intact (SI Ap-
pendix, Fig. S27). In view of the small cross-section of the U-crests,
it is surprising that the links break before the rings, which suggests
that the links lose strength faster than the U-crests. Although this
evidence is indirect, it is consistent with the hypothesis that hy-
drolysis in the majority of the scaffold proceeds faster than it does
in the U-crests and that more rapid hydrolysis correlates with
earlier loss of strength.
Finally, our resolution of the apparent disconnect between hy-
drolysis and scaffold strength depends on a small fraction of the
scaffold as a whole—as little as 3%—having a disproportionate
impact on the radial strength of the scaffold. It is known that
U-crests are particularly important; upon overdeployment to fail-
ure, fractures predominantly occur in U-crests. By design, radial
loading tends to impose tension and compression at the Y-, W-, and
U-crests (defined in Fig. 1A). Among these, the U-crests have the
smallest cross-section; consequently, U-crests are the sites where
the material is subjected to the highest stress. Therefore, it is
plausible that the small fraction of the total scaffold material (ca.
3%) that is located at the U-crests could play a particularly im-
portant role in scaffold strength.
The rest of the discussion is devoted to relating lessons learned
from this study of the clinically approved scaffold to past and future
scaffolds. After examining multiple scaffolds (n = 3 for scaffolds at
each hydrolysis time), several U-crests per scaffold, many sections
from each U-crest, and hundreds of diffraction patterns, we have
observed that the materials and processing are consistent and re-
producible. This is significant in light of substantial literature on
PLLA that shows that hydrolysis kinetics and strength are sensi-
tive to subtle changes in residual monomer content, Mn, and
processing history (27). For example, inclusion of 7% monomer in
compression-molded PLLA increased the rate of in vivo degra-
dation by ∼66% during the first week (38). An increase in Mn has
the opposite effect on the rate of degradation—an increase in
chain length decreases the carboxyl group concentration, which in
turn reduces the rate of hydrolysis (27). The PLLA morphology
influences hydrolysis: Porosity accelerates degradation (34, 35),
while PLLA crystallites are less susceptible to hydrolysis than
amorphous material (26, 27, 33). Relatively subtle changes from
the first- to second-generation Abbott BVS reduced the extent of
hydrolysis in the first 18 M from the first-generation scaffold losing
half its mass (7) to the second-generation BVS (the focus of this
paper) losing only ∼10% of its initial mass over the same period (SI
Appendix, Fig. S1C). Therefore, the degradation behavior of BVSs
might be specific to the chemical composition of the PLLA and the
particular processing conditions that were used.
The magnitude of the effects of material and processing is ev-
ident in a recent report on scaffolds that used a different PLLA
grade, processing conditions, and laser-cut architecture for
which the crimping process is detrimental to scaffold integrity
(36). Among the differences in the processing conditions, the
temperature during crimping may have contributed strongly to
detrimental morphological changes during crimping: That study
examined scaffolds crimped at room temperature (36), a tem-
perature at which PLLA is brittle. Polarized Raman microscopy
revealed that within 110 d the interior of the scaffold had lost
crystallinity and orientation. Rapid degradation may result from
residual monomer, lower stereoregularity, lower initial Mn,
lower crystallinity, or some porosity. Some combination of these
effects may be relevant to the scaffold that degrades rapidly. The
study attributes rapid hydrolysis to crimping-induced gradients in
morphology (36). In this paper, we reach a very different con-
clusion for scaffolds that are crimped in the vicinity of their glass
transition temperature and undergo changes in morphology that
increase strength and delay hydrolysis where it is needed most—
in the U-crests (28).
Conclusions
The clinically approved BVS exhibits an intriguing trend with
hydrolysis—it suffers a ∼40% decrease in the PLLA Mn after
9 mo of degradation, yet it has radial strength comparable to its
initial state. This disconnect between Mn and radial strength has
remained unresolved for nearly 10 y. Microdiffraction data ac-
quired on a BVS hydrolyzed for 9 mo suggest that the lasting
strength of the BVS has its origins in structural transformations
created during crimping, particularly at U-crests. Crimping sub-
jects the material in the vicinity of the symmetry plane of U-crests
to tensile elongation at the OB, which increases the degree and
orientation of crystallinity at the OB. This morphology created at
the OB, which extends ∼100 μm across the symmetry plane of the
U-crests, resists hydrolysis and provides strength where the cross-
sectional area is the narrowest (at the diamond-shaped void, the
IB-to-OB distance is ∼50 μm) and the stress is highest during
radial loading. This region is so small (<3% of the total mass of
the scaffold) that the Mn decrease measured for the scaffold as a
whole could differ substantially from that in the U-crest (SI Ap-
pendix, Fig. S1B). We hypothesize that the measured Mn is
dominated by the arms and links, which experience relatively low
stress; therefore, theMn in arms and links could drop significantly
before it would alter the ability of the scaffold to withstand a radial
load. It is the strength of the material at the point where stress is
concentrated, here the U-crest, that governs the radial load the
structure can support.
The future of bioresorbable scaffolds depends on further ad-
vances in materials. Clinically, the approved BVSs are associated
with a higher incidence of definite or probable thrombosis than
metal stents [∼1.3% for BVS vs. 0.6% for metal stents at the
12-mo follow-up; sample size: 3,253 patients received BVS and
2,315 received metal stents (13)]. Experts suspect the irregular
blood flow over the 150-μm-thick device relative to the 80-μm-thick
metal stents plays a role in thrombosis (13). The thin profile of
metal stents also allows treatment of a wider range of lesions, in-
cluding smaller and/or curved blood vessels. Thus, a stronger bio-
resorbable material is needed so that a thinner scaffold can support
the blood vessel walls.
The present findings highlight the important role of processing
in creating an unusually strong and hydrolysis-resistant morphol-
ogy in PLLA. In the currently approved BVS, this morphology
facilitates deployment (28) and maintains radial strength for
months after implantation. The stark difference between another
recent study (36) and the present study is reminiscent of the dif-
ference between the first- and second-generation BVS. Conse-
quently, the ability of the OB of the clinically approved BVS to
resist hydrolysis can be regarded as an existence proof that it is
possible to tailor the PLLA microstructure to produce stronger
PLLA and enable thinner scaffolds.
Materials and Methods
SEM of As-Deployed Scaffolds. Deployed scaffolds were mounted on SEM stubs
using carbon tape and sputter-coated with gold to improve conductivity.
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Micrographs were acquired on a Hitachi S-4800 field emission microscope at
Abbott Vascular (Fig. 1B).
In Vitro Hydrolysis of Deployed Scaffolds. Scaffolds from the same batch of as-
deployed BVSs were subjected to hydrolysis after deployment. The first group
was removed from solution soon after deployment (0 M scaffolds) to halt
hydrolysis and stored at −20 °C to prevent aging. The second and third
groups were subjected to an additional 9 (9 M scaffolds) and 18 mo (18 M
scaffolds) of hydrolysis in PBS at 37 °C before storage at −20 °C.
Microtoming Deployed Hydrolyzed Scaffolds. Microtomed sections of deployed,
hydrolyzed scaffolds were provided by Abbott Vascular. Deployed scaffolds
were first embedded in a methyl methacrylate-basedmedium (Technovit 7100,
120-min cure at 25 °C) and were then sectioned using a Powertome XL Ultra-
Microtome. Consecutive 15-μm-thick sections were cut parallel to the θ–z plane
of the scaffold from the OD surface to the ID surface (Fig. 1C). The microtome
was maintained at −75 °C to minimize the impact of sectioning on the
scaffold’s microstructure.
Polarized Light Microscopy of the Microtomed Sections. Polarized light mi-
crographs (magnification of 4×, 10×, and 32×) of deployed U-sections were
acquired through crossed linear polarizers on a Zeiss Universal microscope
equipped with a Cannon EOS DS30 camera for image acquisition. Composite
32× images were prepared by stitching individual images in Adobe Photo-
shop and Illustrator (boundaries indicated by dashed lines in Figs. 2 and 4
and SI Appendix, Figs. S8, S10, and S13–S17).
X-Ray Microdiffraction on Microtomed Sections of Deployed Scaffolds. Micro-
diffraction datawere acquired at beamline 2-ID-D (200-nm spot size, λ = 1.18Å)
of the Advanced Photon Source at the Argonne National Labs. Images were
acquired on a Mar165 CCD detector (2,048 × 2,048 pixels) at a sample to de-
tector distance of 80.82 mm. Details regarding sample acquisition and back-
ground subtraction are provided in SI Appendix, Figs. S28–S33. A detailed
description of the beamline optics can be found in the literature (39).
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